SQ641

SQ641 is a translocase I (TL1) inhibitor that blocks peptidoglycan biosynthesis. SQ641 exerts bactericidal activity against Mycobacterium tuberculosis and has a prolonged post-antibiotic effect. SQ641 shows synergistic activity with Ethambutol (HY-B0535), Streptomycin (HY-B1906), and SQ109 (HY-14989), and is able to suppress the emergence of drug-resistant mycobacterial mutants. SQ641-derived phospholipid-based nanoemulsion formulation SQ641-NE exhibits intracellular activity against Mycobacterium tuberculosis in macrophages and reduces splenic CFU in mouse tuberculosis models. SQ641 in TPGS-solubilized solutions or TPGS micelles reduces lung CFU. SQ641 can be used for research on tuberculosis.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • No. CAS: 254449-23-5
  • Fòrmula: C34H51N5O13
  • Peso molecular:737.80
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Actividad biológica
  • Chemical Information
  • Protocolo
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00